These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1801354)

  • 61. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.
    Just M; Berger R; Just V
    Postgrad Med J; 1987; 63 Suppl 2():121-3. PubMed ID: 3317346
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenicity of a DNA-recombinant hepatitis B vaccine (Engerix B) given at 3, 5 and 11 months of age with a new schedule suitable for mass vaccination programmes.
    Piazza M; Da Villa G; Picciotto L; Abrescia N; Guadagnino V; Vegnente A; Iorio R; Cimmino L; Memoli AM
    Boll Soc Ital Biol Sper; 1989 Oct; 65(10):1003-8. PubMed ID: 2533872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of the immunogenicity of a recombinant vaccine against hepatitis B containing S and pre-S2 sequences using two different schedules.
    Gizaris V; Roumeliotou A; Ktenas E; Papoutsakis G; Papaevangelou G
    Vaccine; 1993 Nov; 11(14):1445-7. PubMed ID: 8310765
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Immune response to hepatitis B vaccine in neonates born to mothers with various infection status of hepatitis B virus].
    Yin SR
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):198-202. PubMed ID: 2805044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunogenicity of a yeast-derived hepatitis B vaccine (Engerix-B) in healthy young adults.
    Crovari P; Crovari PC; Petrilli RC; Icardi GC; Bonanni P
    Postgrad Med J; 1987; 63 Suppl 2():161-4. PubMed ID: 3317356
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants.
    Panda SK; Ramesh R; Rao KV; Gupta A; Zuckerman AJ; Nayak NC
    J Med Virol; 1991 Dec; 35(4):297-302. PubMed ID: 1802958
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
    Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
    Lo KJ; Tsai YT; Lee SD; Wu TC; Wang JY; Chen GH; Yeh CL; Chiang BN; Yeh SH; Goudeau A
    J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
    Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses.
    Resti M; Azzari C; Rossi ME; Adami Lami C; Tucci F; Vierucci A
    Vaccine; 1991 Jan; 9(1):15-8. PubMed ID: 2008795
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity.
    Yap I; Guan R; Chan SH
    Vaccine; 1992; 10(7):439-42. PubMed ID: 1535170
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunogenicity of hepatitis B vaccine simultaneously administered with the expanded programme on immunisation (EPI).
    Tsega E; Tafesse B; Nordenfelt E; Wolde-Hawariat G; Hansson BG; Lindberg J
    J Med Virol; 1990 Dec; 32(4):232-5. PubMed ID: 2150529
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine.
    Coursaget P; Bringer L; Sarr G; Bourdil C; Fritzell B; Blondeau C; Yvonnet B; Chiron JP; Jeannée E; Guindo S
    Vaccine; 1992; 10(6):379-82. PubMed ID: 1534640
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B immunization of newborns according to a two dose protocol.
    Perrin J; Coursaget P; Ntareme F; Chiron JP
    Vaccine; 1986 Dec; 4(4):241-4. PubMed ID: 3541427
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians.
    Hadler SC; de Monzon MA; Lugo DR; Perez M
    Vaccine; 1989 Apr; 7(2):106-10. PubMed ID: 2526419
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatitis B infection in infants after neonatal immunization.
    Ip HM; Wong VC; Lelie PN; Reesink HW; Schaasberg W; Yeung CY; Ma HK
    Acta Paediatr Jpn; 1989 Dec; 31(6):654-8. PubMed ID: 2533786
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence of hepatitis B virus infection in the Austral archipelago, French Polynesia: identification of transmission patterns for the formulation of immunization strategies.
    Boutin JP; Sainte Marie FF; Cartel JL; Cardines R; Girard M; Roux J
    Trans R Soc Trop Med Hyg; 1990; 84(2):283-7. PubMed ID: 2389322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.